Clinical Trial Update: Single Agent Armodafinil for Patient-Reported Fatigue Following Radiation Therapy for Head and Neck Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating single-agent armodafinil for patient-reported fatigue after radiation therapy in head and neck cancer; study completed with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fatigue
• Head and Neck Cancer

Drugs mentioned

• Armodafinil (armodafinil)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Head And Neck Cancer, Fatigue | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-02-14